1. Home
  2. XENE vs WMK Comparison

XENE vs WMK Comparison

Compare XENE & WMK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XENE
  • WMK
  • Stock Information
  • Founded
  • XENE 1996
  • WMK 1912
  • Country
  • XENE Canada
  • WMK United States
  • Employees
  • XENE N/A
  • WMK N/A
  • Industry
  • XENE Biotechnology: Pharmaceutical Preparations
  • WMK Food Chains
  • Sector
  • XENE Health Care
  • WMK Consumer Staples
  • Exchange
  • XENE Nasdaq
  • WMK Nasdaq
  • Market Cap
  • XENE 2.5B
  • WMK 2.2B
  • IPO Year
  • XENE 2014
  • WMK N/A
  • Fundamental
  • Price
  • XENE $36.13
  • WMK $80.53
  • Analyst Decision
  • XENE Strong Buy
  • WMK
  • Analyst Count
  • XENE 9
  • WMK 0
  • Target Price
  • XENE $56.22
  • WMK N/A
  • AVG Volume (30 Days)
  • XENE 862.0K
  • WMK 135.1K
  • Earning Date
  • XENE 05-12-2025
  • WMK 05-07-2025
  • Dividend Yield
  • XENE N/A
  • WMK 1.62%
  • EPS Growth
  • XENE N/A
  • WMK 6.00
  • EPS
  • XENE N/A
  • WMK 3.99
  • Revenue
  • XENE N/A
  • WMK $4,810,301,000.00
  • Revenue This Year
  • XENE N/A
  • WMK N/A
  • Revenue Next Year
  • XENE $1,553.36
  • WMK N/A
  • P/E Ratio
  • XENE N/A
  • WMK $22.12
  • Revenue Growth
  • XENE N/A
  • WMK 1.70
  • 52 Week Low
  • XENE $26.74
  • WMK $60.93
  • 52 Week High
  • XENE $46.00
  • WMK $88.60
  • Technical
  • Relative Strength Index (RSI)
  • XENE 49.08
  • WMK 44.74
  • Support Level
  • XENE $37.46
  • WMK $80.81
  • Resistance Level
  • XENE $39.01
  • WMK $90.23
  • Average True Range (ATR)
  • XENE 1.68
  • WMK 2.57
  • MACD
  • XENE -0.14
  • WMK -0.15
  • Stochastic Oscillator
  • XENE 48.59
  • WMK 0.61

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

About WMK Weis Markets Inc.

Weis Markets Inc is a U.S.-based company that is principally engaged in retailing food products in Pennsylvania and surrounding states. The company's products mainly belong to the following categories: center-store goods, fresh goods, pharmacy services, fuel, and others. The center-store goods include groceries, dairy products, frozen foods, alcoholic beverages, and general merchandise items. The fresh goods include meats, seafood, floral, prepared foods, and bakery products. The center-store goods and fresh goods jointly account for the majority of the company's total revenue.

Share on Social Networks: